Strand Therapeutics is an early-stage biotechnology company genetically programming revolutionary therapies to improve the lives of patients. Through pioneering work developed at MIT, Strand is building the world's first smart mRNA therapeutics. Strand is expanding their innovative and rapidly expanding team that understands the value of working at a startup. Strand Therapeutics is a resident company of Johnson & Johnson Innovation, JLABS, a premier life science incubator program.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/04/19 | $6,000,000 | Seed |
Alexandria Venture Investments Playground Global  | undisclosed |
| 11/29/22 | $45,000,000 | Series A |
Eli Lilly and Company FPV Ventures Playground Global Potentum Partners | undisclosed |
| 08/07/25 | $153,000,000 | Series B |
Alderline Group Amgen Ventures ANRI Eli Lilly and Company FPV Ventures Gradiant Corporation ICONIQ Capital JIC Venture Growth Investments Kinnevik LG Technology Ventures Playground Global Potentum Partners Regeneron Ventures | undisclosed |
